Patents by Inventor Yanping Xu

Yanping Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12224978
    Abstract: A packet processing method and apparatus are provided. The method includes: on a forwarding path of an IPv6 packet, a key node (for example, a firewall) signs a packet, and a downstream apparatus of the key node verifies the signature, to determine whether the packet passes through the key node in a forwarding process. According to this application, the key node performs checking, to effectively prevent a packet which packet header is modified by attackers from bypassing the key node.
    Type: Grant
    Filed: May 10, 2023
    Date of Patent: February 11, 2025
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Yanping Xu, Liang Xia, Xiaohui Tong
  • Publication number: 20250005825
    Abstract: Provided is a real scene image editing method based on hierarchically classified text guidance, including: firstly selecting a hierarchical multi-label text classification model and hierarchically classify an input style description text; obtaining a latent vector of an indoor scene image and dividing the latent vector; training latent space residual mappers which are divided into four groups for generating details of a layout, an object, an attribute, and a color in the scene image, and selectively training a mapping model with a secondary word obtained by a text classification model; inputting a tertiary word obtained by the text classification model to a contrastive language-image pre-training (CLIP) network and controlling training of the mapping network by utilizing a CLIP loss; hierarchically inputting the latent vector to the mapping network to obtain a bias vector, summing the bias vector with an original vector for inputting to the StyleGAN to obtain an edited image.
    Type: Application
    Filed: October 9, 2023
    Publication date: January 2, 2025
    Inventors: Hua Zhang, Lingjun Zhang, Tingcong Ye, Yanping Xu, Yifan Wu, Muwei Wang, Yizhang Luo
  • Publication number: 20240417405
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, myelodysplastic syndrome (MDS) and diabetes.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 19, 2024
    Inventors: Olivier Alexis Georges Querolle, Xuedong Dai, Wei Cai, Johannes Wilhelmus J. Thuring, Lichao Fang, Ming Li, Lianzhu Liu, Yingtao Liu, Luoheng Qin, Jianping Wu, Yanping Xu, Patrick Rene Angibaud, Helene France Solange Colombeo, Isbelle Noelle Constance Pilatte, Virginie Sophie Poncelet, Carsten Sven Kramer, Vineet Pande, Xiangjun Deng
  • Publication number: 20240391900
    Abstract: Provided are novel compounds of general formula (I) that inhibit RIP1 kinase or a pharmaceutically acceptable salt thereof, a composition comprising such compounds, and use of such compounds in inhibiting programmed necrosis, inhibiting RIP1 kinase, or treating or preventing a disease that is at least partially mediated by RIP1 kinase.
    Type: Application
    Filed: September 14, 2022
    Publication date: November 28, 2024
    Inventors: Yaning Su, Hanying Ruan, Zhiyuan Zhang, Yanping Xu, Yimin Jianng
  • Publication number: 20240372806
    Abstract: Embodiments of this application disclose a packet sending method. A first IP packet may be obtained, where a packet header of the first IP packet includes a tenant identifier of a tenant corresponding to the first IP packet. After the first IP packet is obtained, the first IP packet is sent to a VAS device, where the VAS device is configured to perform, based on the tenant identifier, a value-added service corresponding to the tenant. Because the packet header of the first IP packet includes the tenant identifier of the tenant corresponding to the first IP packet, after receiving the first IP packet, the VAS device may obtain the corresponding tenant identifier of the tenant by parsing the first IP packet, and further perform, based on the tenant identifier, the value-added service corresponding to the tenant.
    Type: Application
    Filed: July 16, 2024
    Publication date: November 7, 2024
    Inventors: Yanping Xu, Yaqun Xiao, Yunxing Li
  • Publication number: 20240360114
    Abstract: This disclosure provides compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating various diseases and conditions, e.g., those involving ferroptosis.
    Type: Application
    Filed: August 9, 2022
    Publication date: October 31, 2024
    Inventors: Jianguang HAN, Weijie HOU, Zhiyuan ZHANG, Yanping XU, Yimin JIANG, Xingyu XU
  • Publication number: 20240327393
    Abstract: Provided are compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating various diseases and conditions, e.g., those involving ferroptosis.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 3, 2024
    Inventors: Jianguang HAN, Zhiyuan ZHANG, Weijie HOU, Yimin JIANG, Yanping XU
  • Publication number: 20240294508
    Abstract: Provided herein are compounds of Formula Ia and Ib, compositions comprising the same, and methods of using the same, including use in treating various diseases and conditions, including those mediated by receptor-interacting protein 1 (RIP1) signaling
    Type: Application
    Filed: May 16, 2022
    Publication date: September 5, 2024
    Inventors: Zhaolan ZHANG, Zhiyuan ZHANG, Yaning SU, Yanping XU
  • Publication number: 20240261292
    Abstract: Disclosed are combinations comprising a therapeutically effective amount of a menin-MLL inhibitor of Formula (I) or a pharmaceutically acceptable salt or a solvate thereof; and a therapeutically effective amount of at least one other therapeutic agent which is a hypomethylating agent, a cytidine deaminase inhibitor, a DNA intercalating agent, a pyrimidine analog, a purine analog, a kinase inhibitor, a CD20 inhibitor, an IDH inhibitor, an immunomodulatory agent or a DHODH inhibitor. Also disclosed are methods for treating a subject who has been diagnosed with cancer using such combinations. Compounds are represented by Formula (I) as follows: wherein R1a, R1b, R2, R3, R4, U, Y1, X1, X2, n1, n2, n3 and n4 are defined herein.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 8, 2024
    Inventors: Nikki Daskalakis, Christina Diane Guttke, Min Chul Kwon, Lucille Angela Ferrante, Kathryn Elizabeth Packman, Eva Christine Pietsch, Ulrike Philippar, Tinne Ann J. Verhulst, Sumia Ali-Ahmed, Balpreet Bhogal, Yu Sun, Wei Cai, Xuedong Dai, Olivier Alexis Georges Querolle, Johannes Wilhelmus J. Thuring, Yingtao Liu, Lianzhu Liu, Yanping Xu, Liqiang Fu, Ming Li, Lichao Fang, Xiangjun Deng, Alicia Tee Fuay Ng, Nicolas Freddy J. Darville, Vineet Pande
  • Publication number: 20240217963
    Abstract: It provides compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating various diseases and conditions, including those mediated by receptor-interacting protein 1 (RIP1) signaling.
    Type: Application
    Filed: March 17, 2022
    Publication date: July 4, 2024
    Inventors: Yaning SU, Zhaolan ZHANG, Yanping XU, Zhiyuan ZHANG
  • Publication number: 20240211825
    Abstract: Disclosed in the present disclosure is a job-shop batch scheduling method based on a dueling double deep Q-network (D3QN) and a genetic algorithm. The present disclosure includes: constructing a mathematical model of a job-shop batch scheduling problem, where a goal of scheduling is to minimize a maximum completion time; determining a batch partition solution to the job-shop batch scheduling problem by the genetic algorithm; crossing and mutating chromosomes in a population; decoding the chromosomes, and obtaining a batch division solution of the workpieces to be machined; and expressing a procedure sequencing problem of the workpiece batches as a disjunctive graph model; performing representative learning on node feature information of a disjunctive graph by using a graph neural network, and extracting a feature state of the procedure sequencing problem; designing a D3QN model structure with priority experience replay, and training the D3QN model; and determining whether a termination condition is satisfied.
    Type: Application
    Filed: December 13, 2023
    Publication date: June 27, 2024
    Applicant: Hangzhou Dianzi University
    Inventors: Yifan Wu, Zhiqiang Wang, Tingcong Ye, Yanping Xu, Hua Zhang, Guojun Dai
  • Patent number: 11990934
    Abstract: Systems and methods are provided for controlling one or more optical amplifiers of a C+L band photonic line system (30) of a telecommunications network in which C-band signals and L-band signals may be transmitted. In one implementation, a method (130) may execute a traffic managing module (23). When executed, the traffic managing module (23) may be configured to enable a processing device (12) to calculate (132) a gain correction profile based on a difference between a saved baseline transmission profile (84) and a measured transmission profile (94) of a surviving band of a photonic line system (30) when another band of the photonic line system (30) is missing or impacted. The traffic managing module (23) may further be configured to enable the processing device (12) to apply (134) the gain correction profile to a respective optical amplifier (46) of the photonic line system (30) to compensate for the difference.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: May 21, 2024
    Assignee: Ciena Corporation
    Inventors: Choudhury A. Al Sayeed, Yanping Xu, David C. Bownass
  • Publication number: 20240014917
    Abstract: Systems and methods of capacity changes in an optical network having a plurality of optical sections include, responsive to a request for a capacity change for a plurality of channels, bundling the plurality of channels into different steps such that all of the plurality of channels are assigned to a step of the different steps; and causing implementation of the different steps across the plurality of optical sections, wherein each section performs the implementation and the bundling between corresponding Optical Add/Drop Multiplexer (OADM) nodes independently and asynchronously from one another.
    Type: Application
    Filed: September 25, 2023
    Publication date: January 11, 2024
    Inventors: Choudhury A. Al Sayeed, David C. Bownass, Yanping Xu
  • Publication number: 20230416226
    Abstract: Provided are azetidine cyclic urea compounds that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the persons health or condition.
    Type: Application
    Filed: May 20, 2021
    Publication date: December 28, 2023
    Inventors: Zhaolan ZHANG, Zhiyuan ZHANG, Yaning SU, Yanping XU
  • Patent number: 11777634
    Abstract: Systems and methods include, responsive to a request for capacity change of X channels, X is an integer >1, on an optical section (14) and at an Optical Add/Drop Multiplexer (OADM) node (12) in an optical network (10), dividing optical spectrum on the optical section into M slots, M is an integer >1, such that the capacity change of X channels takes a maximum of N steps, N is an integer >1; and performing the capacity change of X channels in up to the N steps in an interleaved manner that changes a subset of the X channels in each of the N steps. For each step, the performing can include a maximum of M/N slots of the M slots with spacing between each of the M/N slots not used for the capacity change in a corresponding step. The spacing can be f, (N+f), (2N+f), . . . , M over the optical spectrum, where f is each step, f=1, 2, . . . , N.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: October 3, 2023
    Assignee: Ciena Corporation
    Inventors: Choudhury A. Al Sayeed, David C. Bownass, Yanping Xu
  • Publication number: 20230283588
    Abstract: A packet processing method and apparatus are provided. The method includes: on a forwarding path of an IPv6 packet, a key node (for example, a firewall) signs a packet, and a downstream apparatus of the key node verifies the signature, to determine whether the packet passes through the key node in a forwarding process. According to this application, the key node performs checking, to effectively prevent a packet which packet header is modified by attackers from bypassing the key node.
    Type: Application
    Filed: May 10, 2023
    Publication date: September 7, 2023
    Inventors: Yanping Xu, Liang Xia, Xiaohui Tong
  • Publication number: 20230242490
    Abstract: The present disclosure discloses a method for the preparation of sulfinpyrazone, which is produced in two steps with a total yield of 48%, wherein thiophenol as the starting material is electrocatalytically coupled with dichloroethane to obtain 2-chloroethyl phenyl sulfoxide, which then undergoes a substitution reaction with 1,2-diphenyl-3,5-pyrazolidinedione to produce sulfinpyrazone. Compared with the prior art, the present method is characterized by high yield, short steps, less three wastes, good chemical selectivity, no need to use strong bases and oxidants, safe and simple operation, and easy to realize industrial production.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 3, 2023
    Inventors: Yu FENG, Wei QIAN, Yanping XU, Liyan GAO, Weihui ZHONG, Fei LING, Tao LIU
  • Publication number: 20230221280
    Abstract: A gel electrophoresis system includes a base module and a camera module. The base module includes a cassette slot for receiving a gel electrophoresis cassette, and a light element that functions to illuminate the gel electrophoresis cassette. The camera module is selectively attachable to and detachable from the base module. When attached to the base module, the camera module facilitates imaging of the gel electrophoresis cassette and provides additional imaging capabilities.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 13, 2023
    Inventors: Beng Heng LIM, Wuh Ken LOH, Hwee Siong KUAH, Jing Han WONG, Jefferson Cruz GANGCUANGCO, Jin Xin ONG, Soo Yong LAU, Yanping XU, Victor SHAPIRO, Zhi Da TEH, Chee Woei CHONG, Kuan Moon BOO
  • Publication number: 20230203019
    Abstract: Provided are piperazine cyclic urea compounds that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), pharmaceutically acceptable salts, hydrates and stereoisomers thereof. Provided are also pharmaceutical compositions, methods of making, and methods of use which include treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 29, 2023
    Inventors: Yaning SU, Zhaolan ZHANG, Zhiyuan ZHANG, Yanping XU
  • Publication number: 20230192662
    Abstract: The present disclosure provides compounds including piperazine heterocyclic amide urea compounds that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 22, 2023
    Inventors: Yaning SU, Zhiyuan ZHANG, Zhaolan ZHANG, Yanping XU